Cargando…
Circulating DNA and frequency of colorectal cancer brain metastases in a presumed high-risk group
This explorative prospective observational pilot study investigated if suggested risk factors, rectal cancer and lung metastases, could add to a relevant detection rate of asymptomatic brain metastases (BM) from colorectal cancer (CRC). Secondary, prognostic biological aspects were investigated by t...
Autores principales: | Callesen, Louise Bach, Boysen, Anders Kindberg, Andersen, Rikke Fredslund, Dalby, Rikke Beese, Spindler, Karen-Lise Garm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616067/ https://www.ncbi.nlm.nih.gov/pubmed/37903871 http://dx.doi.org/10.1038/s41598-023-45939-x |
Ejemplares similares
-
Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015) -
Time for a lead-time definition? Author response to ‘Why the length
of recurrence free survival or “lead-times” can be misleading. Comment on:
Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients
undergoing loco-regional treatment of colorectal cancer metastases: a systematic
review and meta-analysis’
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023) -
Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility
por: Brenner Thomsen, Caroline, et al.
Publicado: (2022) -
Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy
por: Truelsen, Christina Glismand, et al.
Publicado: (2022) -
Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors –
can we RECIST? Focus on colorectal cancer
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023)